Coya Therapeutics Inc. (NASDAQ: COYA)
$5.2500
+0.0100 ( 0% ) 7.1K
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.